Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Veronica Francardo
Based on 11 articles published since 2010
(Why 11 articles?)
||||
Expertise Level
The expertise of Veronica Francardo ranks in the
  • Top 0.66%
  • ... of 89,464 published authors worldwide on Parkinson Disease
  • ... from 2010 through 2020
  • ... based on contributions to 11 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Francardo, Veronica   ·   Francardo, V
Work Locations
Details
Most likely:    Lund University      
2018
  • Department of Biomedical Sciences, Section of Physiology, University of Cagliari, Cittadella Universitaria, SS554 Km 4.5, 09042, Monserrato, Italy. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Pubmed 29242978
  • Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, BMC F11, SE-22184, Lund, Sweden. · Pubmed 29237549
2017
  • Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. Electronic address: · Departments Neurology, Psychiatry, Pharmacology, Columbia University Medical Center: Division of Molecular Therapeutics, New York State Psychiatric Institute, New York 10032, NY, USA. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. Electronic address: · Pubmed 28988910
2016
  • Basal Ganglia Pathophysiology Unit, Dept. Exp. Medical Science, Lund University, BMC F11, 221 84 Lund, Sweden. Electronic address: · Basal Ganglia Pathophysiology Unit, Dept. Exp. Medical Science, Lund University, BMC F11, 221 84 Lund, Sweden. · Basal Ganglia Pathophysiology Unit, Dept. Exp. Medical Science, Lund University, BMC F11, 221 84 Lund, Sweden. Electronic address: · Pubmed 27312773
  • Laboratory of Molecular Neurosurgery, Department of Neurological Surgery, Weill Cornell Medical College, New York, NY 10065; · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Sciences, Lund University, 221 00 Lund, Sweden; · Translational Neuropharmacology, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institute, 171 76 Stockholm, Sweden; · Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10065 · Laboratory of Molecular Neurosurgery, Department of Neurological Surgery, Weill Cornell Medical College, New York, NY 10065; · Pubmed 26787858
2015
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; Department of Neurology, University Hospital Bordeaux, France. · Laboratory of Neurophysiology, Fondazione Santa Lucia, IRCCS, Rome, Italy. · Division of Neuroscience, Institute of Experimental Neurology, San Raffaele Scientific Institute, 20132 Milan, Italy. · Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Department of Neurology, Columbia University, New York, USA. · Pacific Parkinson's Research Centre and National Parkinson Foundation Centre of Excellence, University of British Columbia, Vancouver, Canada. · Department of Biomedical Sciences, Section of Neuropsychopharmacology, Cagliari University, 09124 Cagliari, Italy. · Univ. de Bordeaux, Institut Interdisciplinaire de neurosciences, UMR 5297, 33000 Bordeaux, France; CNRS, Institut Interdisciplinaire de neurosciences, UMR 5297, 33000 Bordeaux, France. · Department of Neurology, Hospital Universitario Donostia and Neuroscience Unit, Bio Donostia Research Institute, San Sebastian, Spain. · Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Center for Health Sciences, SRI International, CA 94025, USA. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Ferrara, Italy. · Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, 20133 Milano, Italy. · Department of Biomedical Sciences, Physiology Section, Cagliari University, Cagliari, Italy. · Motac Neuroscience Ltd, Manchester, UK. · Michigan State University, College of Human Medicine, Department of Translational Science and Molecular Medicine & The Udall Center of Excellence in Parkinson's Disease Research, 333 Bostwick Ave NE, Grand Rapids, MI 49503, USA. · Morton & Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Ontario M4T 2S8, Canada. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, UK. Electronic address: · Pubmed 26209473
  • From the Clinical Memory Research Unit, Department of Clinical Sciences (S.J., E.L., O.H.), Lund University, Malmö · the Department of Clinical Sciences (D.L., S.H.), Division of Psychiatry (D.L.), Department of Experimental Medical Science (V.F., M.A.C.), and Clinical Sciences, Diagnostic Radiology (D.v.W.), Lund University, Lund · Psychiatry Skåne (D.L.), Lund · the Department of Neurology (S.H.) and Memory Clinic (E.L., O.H.), Skåne University Hospital, Lund · Institute of Neuroscience and Physiology (H.Z., K.B.), Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden · UCL Institute of Neurology (H.Z.), London, UK · The Torsten Söderberg Professorship in Medicine at the Royal Swedish Academy of Sciences (K.B.), Stockholm, Sweden · Department of Neurology (C.H.A.), Mayo Clinic, Scottsdale · Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ · and Imaging and Function (D.v.W.), Skåne University Health Care, Lund, Sweden. · Pubmed 26511451
2014
  • Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, BMC F11, Sölvegatan 19, 22184 Lund, Sweden. · Pubmed 24262181
  • 1 Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, BMC F11, Lund University, Lund, Sweden · 1 Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, BMC F11, Lund University, Lund, Sweden. · 2 Laboratory for Experimental Brain Research, Division of Neurosurgery, Department of Clinical Sciences, Wallenberg Neuroscience Centre, Lund University, Lund, Sweden. · 3 Department of Pharmacology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden. · Pubmed 24755275
2011
  • Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, BMC F11, Sölvegatan 19, 221 84 Lund, Sweden. · Pubmed 21310234
2012
  • Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, BMC F11, SE-221 84 Lund, Sweden. · Pubmed 22465440
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 11 total) written by Veronica Francardo about Parkinson Disease:

  • Animal models of L-DOPA-induced dyskinesia: the 6-OHDA-lesioned rat and mouse. 2018
  • Modeling Parkinson's disease and treatment complications in rodents: Potentials and pitfalls of the current options. 2018
  • Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease. 2017
  • Dramatic differences in susceptibility to l-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion. 2016
  • Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice. 2016
  • Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. 2015
  • Increased CSF biomarkers of angiogenesis in Parkinson disease. 2015
  • Investigating the molecular mechanisms of L-DOPA-induced dyskinesia in the mouse. 2014
  • Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism. 2014
  • Animal models of L-DOPA-induced dyskinesia: an update on the current options. 2012
Show List of Full Article Records
Google Searches

Learn more about Veronica Francardo using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Lund University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Lund University
2018
  • Department of Biomedical Sciences, Section of Physiology, University of Cagliari, Cittadella Universitaria, SS554 Km 4.5, 09042, Monserrato, Italy. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Pubmed 29242978
  • Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, BMC F11, SE-22184, Lund, Sweden. · Pubmed 29237549
2017
  • Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. Electronic address: · Departments Neurology, Psychiatry, Pharmacology, Columbia University Medical Center: Division of Molecular Therapeutics, New York State Psychiatric Institute, New York 10032, NY, USA. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. Electronic address: · Pubmed 28988910
2016
  • Basal Ganglia Pathophysiology Unit, Dept. Exp. Medical Science, Lund University, BMC F11, 221 84 Lund, Sweden. Electronic address: · Basal Ganglia Pathophysiology Unit, Dept. Exp. Medical Science, Lund University, BMC F11, 221 84 Lund, Sweden. · Basal Ganglia Pathophysiology Unit, Dept. Exp. Medical Science, Lund University, BMC F11, 221 84 Lund, Sweden. Electronic address: · Pubmed 27312773
  • Laboratory of Molecular Neurosurgery, Department of Neurological Surgery, Weill Cornell Medical College, New York, NY 10065; · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Sciences, Lund University, 221 00 Lund, Sweden; · Translational Neuropharmacology, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institute, 171 76 Stockholm, Sweden; · Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10065 · Laboratory of Molecular Neurosurgery, Department of Neurological Surgery, Weill Cornell Medical College, New York, NY 10065; · Pubmed 26787858
2015
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; Department of Neurology, University Hospital Bordeaux, France. · Laboratory of Neurophysiology, Fondazione Santa Lucia, IRCCS, Rome, Italy. · Division of Neuroscience, Institute of Experimental Neurology, San Raffaele Scientific Institute, 20132 Milan, Italy. · Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. · Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. · Department of Neurology, Columbia University, New York, USA. · Pacific Parkinson's Research Centre and National Parkinson Foundation Centre of Excellence, University of British Columbia, Vancouver, Canada. · Department of Biomedical Sciences, Section of Neuropsychopharmacology, Cagliari University, 09124 Cagliari, Italy. · Univ. de Bordeaux, Institut Interdisciplinaire de neurosciences, UMR 5297, 33000 Bordeaux, France; CNRS, Institut Interdisciplinaire de neurosciences, UMR 5297, 33000 Bordeaux, France. · Department of Neurology, Hospital Universitario Donostia and Neuroscience Unit, Bio Donostia Research Institute, San Sebastian, Spain. · Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. · Center for Health Sciences, SRI International, CA 94025, USA. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Ferrara, Italy. · Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, 20133 Milano, Italy. · Department of Biomedical Sciences, Physiology Section, Cagliari University, Cagliari, Italy. · Motac Neuroscience Ltd, Manchester, UK. · Michigan State University, College of Human Medicine, Department of Translational Science and Molecular Medicine & The Udall Center of Excellence in Parkinson's Disease Research, 333 Bostwick Ave NE, Grand Rapids, MI 49503, USA. · Morton & Gloria Shulman Movement Disorders Center, Toronto Western Hospital, Toronto, Ontario M4T 2S8, Canada. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, UK. Electronic address: · Pubmed 26209473
  • From the Clinical Memory Research Unit, Department of Clinical Sciences (S.J., E.L., O.H.), Lund University, Malmö · the Department of Clinical Sciences (D.L., S.H.), Division of Psychiatry (D.L.), Department of Experimental Medical Science (V.F., M.A.C.), and Clinical Sciences, Diagnostic Radiology (D.v.W.), Lund University, Lund · Psychiatry Skåne (D.L.), Lund · the Department of Neurology (S.H.) and Memory Clinic (E.L., O.H.), Skåne University Hospital, Lund · Institute of Neuroscience and Physiology (H.Z., K.B.), Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden · UCL Institute of Neurology (H.Z.), London, UK · The Torsten Söderberg Professorship in Medicine at the Royal Swedish Academy of Sciences (K.B.), Stockholm, Sweden · Department of Neurology (C.H.A.), Mayo Clinic, Scottsdale · Banner Sun Health Research Institute (T.G.B., G.E.S.), Sun City, AZ · and Imaging and Function (D.v.W.), Skåne University Health Care, Lund, Sweden. · Pubmed 26511451
2014
  • Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, BMC F11, Sölvegatan 19, 22184 Lund, Sweden. · Pubmed 24262181
  • 1 Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, BMC F11, Lund University, Lund, Sweden · 1 Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, BMC F11, Lund University, Lund, Sweden. · 2 Laboratory for Experimental Brain Research, Division of Neurosurgery, Department of Clinical Sciences, Wallenberg Neuroscience Centre, Lund University, Lund, Sweden. · 3 Department of Pharmacology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden. · Pubmed 24755275
2011
  • Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, BMC F11, Sölvegatan 19, 221 84 Lund, Sweden. · Pubmed 21310234
2012
  • Basal Ganglia Pathophysiology Unit, Department of Experimental Medical Science, Lund University, BMC F11, SE-221 84 Lund, Sweden. · Pubmed 22465440
Yearly article counts 00212220110
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.